Executive Summary
This digest covers $662.4M in federal contract obligations across five awards, with only one defense-related contract (HII Mission Technologies at $157.3M) and four civilian awards totaling $505.1M. The dominant theme is stable, recurring civilian agency spending—particularly healthcare (VA OptumRx, CMS Noridian) and workforce training (DOL Management & Training)—rather than defense growth.
The highest-conviction signal is the Noridian Healthcare Solutions CMS contract ($116.8M obligated, $573.6M potential), which offers low-risk cost-plus award fee revenue through 2032. Key risks include the short duration of the OptumRx VA PBM contract (4 months) and the expired status of the Business Integra NASA IT contract, which limits forward visibility. Investors should watch for option exercises on the Noridian and HII contracts as catalysts for sustained revenue.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Contract Deobligations Alert digest from August 19, 2026.
Investment Signals (4)
- Noridian Healthcare Solutions Secures $573.6M CMS Medicare Contract (HIGH)▲
Noridian's cost-plus award fee contract with CMS provides low-risk, stable margins and a potential 10-year revenue stream, with $116.8M obligated immediately. This is the highest-conviction signal in the digest.
- HII Mission Technologies Wins $240M Navy Engineering Support Contract (MEDIUM)▲
HII's $157.3M delivery order (options up to $240.1M) for Navy engineering services at Pearl Harbor provides a five-year revenue stream, though the negative outlayed amount (-$100,687) warrants monitoring.
- OptumRx VA PBM Contract is Short-Duration, High-Run-Rate (HIGH)▲
UnitedHealth Group's OptumRx won a $136.95M firm-fixed-price VA PBM contract covering only four months (June–September 2025), implying $34M/month but no multi-year visibility. Fixed-price shifts cost risk to OptumRx.
- Business Integra NASA IT Contract is Expired (HIGH)▲
Business Integra's $149.3M obligated NASA IT contract ended July 2022, with no follow-on identified. This limits future revenue visibility and signals potential gap in NASA IT spending for this contractor.
Risk Flags (4)
- Concentration [MEDIUM RISK]▼
Only one defense contract (HII) out of five awards, representing 23.7% of total obligation. The digest is heavily weighted toward civilian healthcare and training programs, which may underperform if defense spending accelerates.
- Budget [HIGH RISK]▼
The OptumRx VA PBM contract is only 4 months long, creating a cliff risk if not renewed or extended. VA pharmacy budgets are stable but short-term awards signal potential recompetition or pricing pressure.
- Execution [MEDIUM RISK]▼
HII Mission Technologies contract has a negative outlayed amount (-$100,687), which may indicate accounting adjustments or early-stage funding issues. This could signal execution risk or delayed revenue recognition.
- Competition [HIGH RISK]▼
Management & Training Corporation's DOL Job Corps contract ($102.1M obligated) faces recompetition risk as it ends April 2024. Full-and-open competition with no set-aside means no preferential access.
Opportunities (3)
- ◆
Noridian Healthcare Solutions' CMS Medicare contract offers a 10-year, $573.6M potential revenue stream. Option exercises could drive sustained growth for this private contractor in the stable Medicare FFS market.
- ◆
HII Mission Technologies' Navy engineering contract at Pearl Harbor could expand via options ($240.1M potential). This supports HII's diversification into services beyond shipbuilding.
- ◆
Business Integra's expired NASA IT contract was an 8(a) set-aside, indicating strong small business preferences at NASA. New 8(a) opportunities at Goddard could emerge for similar IT support services.
Sector Themes (3)
- ◆
Two of five contracts (OptumRx VA PBM and Noridian CMS) total $253.7M, or 38.3% of total obligation, highlighting strong federal spending on healthcare administration and pharmacy benefits.
- ◆
HII's $157.3M Navy engineering contract underscores its strategy to grow services revenue, reducing reliance on shipbuilding cycles. This is a bullish signal for HII's margin stability.
- ◆
Two contracts (OptumRx: 4 months; Business Integra: expired) have limited forward visibility, signaling that not all large obligations translate to multi-year revenue. Investors must differentiate between one-time and recurring awards.
Watch List (5)
- 👁
{"entity" => "Noridian Healthcare Solutions", "reason" => "Highest-conviction contract with $573.6M potential; option exercises are key catalysts.", "trigger" => "Option exercise announcements for CMS Medicare contract"}
- 👁
{"entity" => "Huntington Ingalls Industries", "reason" => "Only defense contract in digest; negative outlayed amount needs resolution.", "trigger" => "Quarterly outlay updates and option exercise for Navy engineering contract"}
- 👁
{"entity" => "UnitedHealth Group (OptumRx)", "reason" => "Short-duration VA PBM contract creates cliff risk; recompete or extension is critical.", "trigger" => "VA PBM contract extension or recompete RFP before September 2025"}
- 👁
{"entity" => "Management & Training Corporation", "reason" => "DOL Job Corps contract ends April 2024; recompetition risk is high.", "trigger" => "DOL Job Corps recompete RFP or contract extension announcement"}
- 👁
{"entity" => "Business Integra Technology Solutions", "reason" => "Expired NASA contract limits revenue visibility; new awards needed for growth.", "trigger" => "NASA Goddard IT recompete or new 8(a) contract awards"}
Get daily alerts with 4 investment signals, 4 risk alerts, 3 opportunities and full AI analysis of all 5 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Contract Deobligations Alert
🇺🇸 More from United States
View all →August 20, 2026
US Pre-Market SEC Filings Roundup — August 20, 2026
US Pre-Market SEC Filings Roundup
August 20, 2026
USA Corporate Events Calendar — August 20, 2026
USA Corporate Events Calendar
August 20, 2026
US Executive Officer Management Changes SEC — August 20, 2026
US Executive Officer Management Changes SEC
August 20, 2026
US IPO Pipeline SEC S-1 Filings — August 20, 2026
US IPO Pipeline SEC S-1 Filings